Enantiomers of selected fused pyrimidones and uses in the treatment and preventi on of cancer

Details for Australian Patent Application No. 2005273705 (hide)

Owner AstraZeneca AB

Inventors Filla, Sandra Ann; Theoclitou, MarieElena; Aquila, Brian; Pontz, Timothy; Zheng, Xiaolan; Davies, Audrey; Ezhuthachan, Jayachandran; Block, Michael Howard; Russell, Daniel John

Agent Davies Collison Cave

Pub. Number AU-B-2005273705

PCT Pub. Number WO2006/018628

Priority 60/602,366 18.08.04 US

Filing date 16 August 2005

Wipo publication date 23 February 2006

Acceptance publication date 10 December 2009

International Classifications

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 35/00 (2006.01) Antineoplastic agents

C07D 239/00 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 261/00 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

C07D 275/00 (2006.01) Heterocyclic compounds having nitrogen and sulfur as the only ring hetero atoms

C07D 498/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

22 March 2007 PCT application entered the National Phase

  PCT publication WO2006/018628 Priority application(s): WO2006/018628

6 August 2009 Amendment Made

  The nature of the amendment is: Add the name of the co-inventor to read Filla, Sandra Ann

10 December 2009 Application Accepted

  Published as AU-B-2005273705

28 January 2010 Corrigenda

  Applications Accepted - Name Index Under the name AstraZeneca AB, Application No. 2005273705, under INID (54) correct the title to read Enantiomers of selected fused pyrimidones and uses in the treatment and prevention of cancer

8 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005273710-Use of GSK-3 inhibitors for the treatment of prostate cancer

2005273704-Selected fused heterocyclics and uses thereof